This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, US Government as Represented by the Secretary of the Army. Active years: 2001-2013.
Company Filing History:
2 out of 3,693 
2 out of 8,745 
Years Active: 2001-2013
Title: Bruce Ivins: Innovator in Biodefense
Introduction
Bruce Ivins was a notable inventor known for his contributions to biodefense and immunology. He was based in Frederick, MD (US) and held a total of 4 patents. His work primarily focused on methods to prevent infections from bioterrorism agents, showcasing his commitment to public health and safety.
Latest Patents
One of Ivins' significant patents is titled "Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides." This patent details a method for preventing or treating infections caused by bioterrorism agents. It specifically describes how to increase an immune response to such agents using an oligodeoxynucleotide that includes a CpG motif. Additionally, it outlines a method for enhancing the immunogenicity of vaccines against bioterrorism agents using the same oligodeoxynucleotide.
Career Highlights
Throughout his career, Bruce Ivins worked with prominent organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the US Government as represented by the Secretary of the Army. His work in these institutions allowed him to contribute significantly to the field of biodefense.
Collaborations
Ivins collaborated with several notable colleagues, including Dennis M Klinman and Daniela Verthelyi. Their combined expertise in immunology and biodefense further advanced the research and development of effective methods to combat bioterrorism threats.
Conclusion
Bruce Ivins made significant contributions to the field of biodefense through his innovative patents and collaborations. His work continues to impact public health and safety, particularly in the context of bioterrorism preparedness.